The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHon Hai Precsn Regulatory News (HHPD)

Share Price Information for Hon Hai Precsn (HHPD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.52
Bid: 9.41
Ask: 9.52
Change: -0.03 (-0.31%)
Spread: 0.11 (1.169%)
Open: 9.51
High: 9.52
Low: 9.18
Prev. Close: 9.55
HHPD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2018 3rd IFRS Consolidated Financial Statements

14 Nov 2018 11:31

RNS Number : 3491H
Hon Hai Precision Industry Co Ld
14 November 2018
 

HON HAI PRECISION INDUSTRY CO., LTD. AND SUBSIDIARIES CONSOLIDATED SHEETS

2018 3rd IFRS Consolidated Financial Statements

 

Balance Sheet

Accounting Title

2018/09/30

2017/12/31

2017/09/30

  Assets

Current assets

Cash and cash equivalents

694,448,838

642,496,059

613,157,572

Current financial assets at fair value through profit or loss

6,967,725

7,009,541

5,735,886

Current available-for-sale financial assets

0

290

622,408

Current financial assets at amortised cost

139,400,571

0

0

Accounts receivable, net

997,262,663

1,150,428,069

633,048,553

Accounts receivable due from related parties, net

41,909,899

80,066,388

59,367,158

Other receivables

74,712,608

67,700,725

57,771,384

Other receivables due from related parties

64,478,511

82,627,493

5,741,137

Current inventories

724,169,366

560,954,855

519,472,559

Prepayments

17,558,462

20,328,111

14,301,121

Other current assets

0

134,524,586

136,311,250

Total current assets

2,760,908,643

2,746,136,117

2,045,529,028

Non-current assets

Non-current financial assets at fair value through profit or loss

65,861,482

3,040,601

3,178,695

Non-current financial assets at fair value through other comprehensive income

71,628,777

0

0

Non-current available-for-sale financial assets

0

70,868,132

169,959,954

Non-current financial assets at amortised cost

15,415,796

0

0

Non-current financial assets at cost

0

49,861,639

47,074,620

Non-current investments in debt instrument without active market

0

4,571,100

0

Investments accounted for using equity method

157,853,399

151,000,283

138,911,332

Property, plant and equipment

267,228,627

278,204,005

297,492,912

Investment property, net

2,256,628

2,422,523

2,349,393

Intangible assets

30,946,646

9,552,444

9,731,127

Deferred tax assets

21,092,396

15,048,377

16,873,275

Other non-current assets

43,622,968

76,511,392

31,554,300

Total non-current assets

675,906,719

661,080,496

717,125,608

Total assets

3,436,815,362

3,407,216,613

2,762,654,636

  Liabilities and equity

Liabilities

Current liabilities

Current borrowings

569,521,547

418,835,146

304,622,456

Short-term notes and bills payable

899,720

10,960,269

9,767,222

Current financial liabilities at fair value through profit or loss

2,990,795

6,486,348

770,467

Accounts payable

968,319,366

1,119,169,644

685,869,582

Accounts payable to related parties

45,434,872

97,315,119

64,983,995

Other payables

262,604,054

255,696,126

221,348,553

Current tax liabilities

26,877,919

38,439,140

18,466,580

Current provisions

6,379,545

4,796,498

4,206,132

Other current liabilities

38,153,697

73,803,977

95,406,033

Total current liabilities

1,921,181,515

2,025,502,267

1,405,441,020

Non-current liabilities

Non-current financial liabilities at fair value through profit or loss

18,750

0

0

Bonds payable

180,996,884

168,495,189

150,321,255

Non-current portion of non-current borrowings

35,879,364

19,984,818

12,404,308

Deferred tax liabilities

20,696,768

12,541,548

28,832,008

Other non-current liabilities

9,531,825

8,900,336

9,018,437

Total non-current liabilities

247,123,591

209,921,891

200,576,008

Total liabilities

2,168,305,106

2,235,424,158

1,606,017,028

Equity

Equity attributable to owners of parent

Share capital

Ordinary share

138,629,906

173,287,383

173,287,383

Total capital stock

138,629,906

173,287,383

173,287,383

Capital surplus

Capital surplus, additional paid-in capital

88,501,031

88,501,031

88,501,031

Capital surplus, difference between consideration and carrying amount of subsidiaries acquired or disposed

93,573,126

3,300,393

4,845,329

Capital surplus, changes in equity of associates and joint ventures accounted for using equity method

5,392,745

4,972,207

2,359,661

Capital surplus, share options

1,099,253

1,099,253

0

Total capital surplus

188,566,155

97,872,884

95,706,021

Retained earnings

Legal reserve

136,606,364

122,732,924

122,732,924

Special reserve

27,539,310

0

0

Unappropriated retained earnings (accumulated deficit)

716,612,590

717,885,835

646,289,599

Total retained earnings

880,758,264

840,618,759

769,022,523

Other equity interest

Exchange differences on translation of foreign financial statements

-72,125,368

-56,320,437

-50,605,814

Unrealised gains (losses) from financial assets measured at fair value through other comprehensive income

15,065,784

0

0

Unrealized gains (losses) on available-for-sale financial assets

0

28,781,127

82,571,508

Total other equity interest

-57,059,584

-27,539,310

31,965,694

Treasury shares

15,194

18,901

18,901

Total equity attributable to owners of parent

1,150,879,547

1,084,220,815

1,069,962,720

Non-controlling interests

117,630,709

87,571,640

86,674,888

Total equity

1,268,510,256

1,171,792,455

1,156,637,608

Total liabilities and equity

3,436,815,362

3,407,216,613

2,762,654,636

Number of share capital awaiting retirement

0

0

0

Equivalent issue shares of advance receipts for ordinary share

0

0

0

Number of shares in entity held by entity and by its subsidiaries

1,483,078

1,853,848

1,853,848

 

Income Statement

Accounting Title

2018/3rd

2017/3rd

2018/01/01To2018/09/30

2017/01/01To2017/09/30

  Operating revenue

Total operating revenue

1,375,839,799

1,078,891,633

3,483,904,827

2,976,347,954

  Operating costs

Total operating costs

1,295,035,890

1,015,949,316

3,278,633,608

2,778,906,598

  Gross profit (loss) from operations

80,803,909

62,942,317

205,271,219

197,441,356

  Gross profit (loss) from operations

80,803,909

62,942,317

205,271,219

197,441,356

  Operating expenses

Selling expenses

8,658,563

6,494,720

24,459,467

18,076,448

Administrative expenses

20,405,697

19,444,211

55,173,358

53,163,318

Research and development expenses

20,372,998

18,287,442

53,771,793

46,044,526

Total operating expenses

49,437,258

44,226,373

133,404,618

117,284,292

  Net operating income (loss)

31,366,651

18,715,944

71,866,601

80,157,064

  Non-operating income and expenses

Other income

Total other income

21,411,461

14,545,638

49,014,790

38,724,820

Other gains and losses

Other gains and losses, net

-8,686,422

-1,559,511

558,426

-10,473,863

Finance costs

Finance costs, net

14,787,785

10,398,374

37,213,704

27,148,768

Share of profit (loss) of associates and joint ventures accounted for using equity method

Share of profit (loss) of associates and joint ventures accounted for using equity method, net

5,029,954

3,843,075

10,900,382

5,977,372

Total non-operating income and expenses

2,967,208

6,430,828

23,259,894

7,079,561

  Profit (loss) from continuing operations before tax

34,333,859

25,146,772

95,126,495

87,236,625

  Tax expense (income)

Total tax expense (income)

9,781,908

5,481,622

29,183,834

23,445,253

  Profit (loss) from continuing operations

24,551,951

19,665,150

65,942,661

63,791,372

  Profit (loss)

24,551,951

19,665,150

65,942,661

63,791,372

  Other comprehensive income

Components of other comprehensive income that will not be reclassified to profit or loss

Unrealised gains (losses) from investments in equity instruments measured at fair value through other comprehensive income

2,735,041

0

-2,194,623

0

Share of other comprehensive income of associates and joint ventures accounted for using equity method, components of other comprehensive income that will not be reclassified to profit or loss

-1,694,091

0

-6,119,951

0

Components of other comprehensive income that will not be reclassified to profit or loss

1,040,950

0

-8,314,574

0

Components of other comprehensive income that will be reclassified to profit or loss

Exchange differences on translation

-32,959,202

7,199,091

-17,400,822

-37,589,253

Unrealised gains (losses) on valuation of available-for-sale financial assets

0

-13,530,434

0

47,508,317

Share of other comprehensive income of associates and joint ventures accounted for using equity method, components of other comprehensive income that will be reclassified to profit or loss

-1,676,624

-7,951,463

-2,225,559

-1,074,334

Income tax related to components of other comprehensive income that will be reclassified to profit or loss

0

-3,540,050

0

4,711,135

Components of other comprehensive income that will be reclassified to profit or loss

-34,635,826

-10,742,756

-19,626,381

4,133,595

Other comprehensive income, net

-33,594,876

-10,742,756

-27,940,955

4,133,595

  Total comprehensive income

-9,042,925

8,922,394

38,001,706

67,924,967

  Profit (loss), attributable to:

Profit (loss), attributable to owners of parent

24,875,846

21,028,838

66,446,436

67,075,811

Profit (loss), attributable to non-controlling interests

-323,895

-1,363,688

-503,775

-3,284,439

  Comprehensive income attributable to:

Comprehensive income, attributable to owners of parent

-4,947,108

6,080,064

42,532,936

66,533,238

Comprehensive income, attributable to non-controlling interests

-4,095,817

2,842,330

-4,531,230

1,391,729

  Basic earnings per share

Basic earnings (loss) per share from continuing operations

1.57

1.21

3.95

3.87

Total basic earnings per share

1.57

1.21

3.95

3.87

  Diluted earnings per share

Diluted earnings (loss) per share from continuing operations

1.56

1.21

3.93

3.86

Total diluted earnings per share

1.56

1.21

3.93

3.86

 

 

 

Statements of Cash Flows

Accounting Title

2018/01/01To2018/09/30

2017/01/01To2017/09/30

  Cash flows from (used in) operating activities, indirect method

Profit (loss) from continuing operations before tax

95,126,495

87,236,625

Profit (loss) before tax

95,126,495

87,236,625

Adjustments

Adjustments to reconcile profit (loss)

Depreciation expense

42,023,817

43,252,555

Amortization expense

980,536

942,586

Expected credit loss (gain) / Provision (reversal of provision) for bad debt expense

1,065,876

95,738

Net loss (gain) on financial assets or liabilities at fair value through profit or loss

-12,360,729

14,143,231

Interest expense

36,752,255

27,035,741

Interest income

-39,330,350

-33,029,043

Dividend income

-1,346,660

-1,071,704

Share of loss (profit) of associates and joint ventures accounted for using equity method

-10,900,382

-5,977,372

Loss (gain) on disposal of property, plan and equipment

32,387

-31,989

Loss (gain) on disposal of investments

30,069

-776,034

Impairment loss on financial assets

8,339

5,048,957

Total adjustments to reconcile profit (loss)

16,955,158

49,632,666

Changes in operating assets and liabilities

Changes in operating assets

Decrease (increase) in financial assets held for trading

0

-12,802,895

Decrease (increase) in financial assets at fair value through profit or loss, mandatorily measured at fair value

8,051,954

0

Decrease (increase) in notes receivable

-671,823

316,924

Decrease (increase) in accounts receivable

157,994,533

65,726,304

Decrease (increase) in accounts receivable due from related parties

38,156,489

-27,386,313

Decrease (increase) in other receivable

3,706,849

-17,534,306

Decrease (increase) in inventories

-158,684,583

-132,198,498

Decrease (increase) in prepayments

2,769,649

-1,215,618

Total changes in operating assets

51,323,068

-125,094,402

Changes in operating liabilities

Increase (decrease) in accounts payable

-154,550,550

6,814,326

Increase (decrease) in accounts payable to related parties

-51,880,247

34,376,065

Increase (decrease) in other payable

-26,897,140

-820,646

Increase (decrease) in provisions

1,583,047

1,223,096

Increase (decrease) in other current liabilities

-5,029,715

-452,731

Increase (decrease) in net defined benefit liability

2,656

-81,261

Total changes in operating liabilities

-236,771,949

41,058,849

Total changes in operating assets and liabilities

-185,448,881

-84,035,553

Total adjustments

-168,493,723

-34,402,887

Cash inflow (outflow) generated from operations

-73,367,228

52,833,738

Income taxes refund (paid)

-36,966,324

-32,461,650

  Net cash flows from (used in) operating activities

-110,333,552

20,372,088

  Cash flows from (used in) investing activities

Acquisition of financial assets at fair value through other comprehensive income

-7,471,585

0

Proceeds from disposal of financial assets at fair value through other comprehensive income

270,861

0

Acquisition of financial assets at amortised cost

-19,032,495

0

Proceeds from repayments of financial assets at amortised cost

1,379,850

0

Acquisition of financial assets designated at fair value through profit or loss

-4,313,835

-1,389,650

Proceeds from disposal of financial assets designated at fair value through profit or loss

112,953

0

Acquisition of available-for-sale financial assets

0

-157,352

Proceeds from disposal of available-for-sale financial assets

0

862,226

Acquisition of financial assets at cost

0

-22,025,289

Proceeds from disposal of financial assets at cost

0

228,571

Acquisition of investments accounted for using equity method

-4,569,967

-570,702

Net cash flow from acquisition of subsidiaries

-25,839,618

0

Proceeds from capital reduction of investments accounted for using equity method

0

791,383

Acquisition of property, plant and equipment

-47,754,841

-36,569,773

Proceeds from disposal of property, plant and equipment

18,366,021

2,422,218

Decrease in other receivables due from related parties

33,914,580

224,181

Increase in other financial assets

0

-29,564,014

Increase in other non-current assets

-1,135,512

-1,049,429

Increase in other prepayments

-25,018

-508,314

Interest received

37,993,632

32,576,387

Dividends received

4,091,627

4,185,108

Other investing activities

0

-262,511

Net cash flows from (used in) investing activities

-14,013,347

-50,806,960

  Cash flows from (used in) financing activities

Increase in short-term loans

150,686,401

133,150,313

Decrease in short-term notes and bills payable

-10,060,269

-6,223,622

Proceeds from issuing bonds

19,500,000

31,465,700

Repayments of bonds

-32,801,099

-30,818,500

Proceeds from long-term debt

19,739,333

4,849,199

Repayments of long-term debt

-10,113,487

-9,040,082

Increase in other non-current liabilities

381,855

645,385

Cash dividends paid

-34,657,477

-77,979,322

Interest paid

-32,412,697

-26,052,980

Change in non-controlling interests

-365,365

11,306,156

Other financing activities

122,882,261

0

Net cash flows from (used in) financing activities

192,779,456

31,302,247

  Effect of exchange rate changes on cash and cash equivalents

-16,479,778

-20,865,104

  Net increase (decrease) in cash and cash equivalents

51,952,779

-19,997,729

  Cash and cash equivalents at beginning of period

642,496,059

633,155,301

  Cash and cash equivalents at end of period

694,448,838

613,157,572

Cash and cash equivalents reported in the statement of financial position

694,448,838

613,157,572

Statements of Changes in Stockholders' Equity

Ordinary share

Total share capital

Capital surplus

Legal reserve

Special reserve

Unappropriated retained earnings (accumulated deficit)

Total retained earnings

Exchange differences on translation of foreign financial statements

Unrealised gains (losses) on financial assets measured at fair value through other comprehensive income

Unrealized gains (losses) on available-for-sale financial assets

Total other equity interest

Treasury shares

Total equity attributable to owners of parent

Non-controlling interests

Total equity

Equity

173,287,383

173,287,383

97,872,884

122,732,924

0

717,885,835

840,618,759

-56,320,437

0

28,781,127

-27,539,310

-18,901

1,084,220,815

87,571,640

1,171,792,455

Effects of retrospective application and retrospective restatement

0

0

0

0

0

7,309,666

7,309,666

0

23,174,353

-28,781,127

-5,606,774

0

1,702,892

-297,228

1,405,664

Equity at beginning of period after adjustments

173,287,383

173,287,383

97,872,884

122,732,924

0

725,195,501

847,928,425

-56,320,437

23,174,353

0

-33,146,084

-18,901

1,085,923,707

87,274,412

1,173,198,119

Legal reserve appropriated

0

0

0

13,873,440

0

-13,873,440

0

0

0

0

0

0

0

0

0

Special reserve appropriated

0

0

0

0

27,539,310

-27,539,310

0

0

0

0

0

0

0

0

0

Cash dividends of ordinary share

0

0

0

0

0

-34,657,477

-34,657,477

0

0

0

0

0

-34,657,477

0

-34,657,477

Changes in equity of associates and joint ventures accounted for using equity method

0

0

420,538

0

0

0

0

0

0

0

0

0

420,538

0

420,538

Profit (loss)

0

0

0

0

0

66,446,436

66,446,436

0

0

0

0

0

66,446,436

-503,775

65,942,661

Other comprehensive income

0

0

0

0

0

0

0

-15,804,931

-8,108,569

0

-23,913,500

0

-23,913,500

-4,027,455

-27,940,955

Total comprehensive income

0

0

0

0

0

66,446,436

66,446,436

-15,804,931

-8,108,569

0

-23,913,500

0

42,532,936

-4,531,230

38,001,706

Capital reduction

-34,657,477

-34,657,477

0

0

0

0

0

0

0

0

0

3,707

-34,653,770

0

-34,653,770

Changes in ownership interests in subsidiaries

0

0

90,272,733

0

0

0

0

0

0

0

0

0

90,272,733

-365,365

89,907,368

Changes in non-controlling interests

0

0

0

0

0

0

0

0

0

0

0

0

0

35,252,892

35,252,892

Disposal of investments in equity instruments designated at fair value through other comprehensive income

0

0

0

0

0

1,040,880

1,040,880

0

0

0

0

0

1,040,880

0

1,040,880

Increase (decrease) in equity

-34,657,477

-34,657,477

90,693,271

13,873,440

27,539,310

-8,582,911

32,829,839

-15,804,931

-8,108,569

0

-23,913,500

3,707

64,955,840

30,356,297

95,312,137

Equity

138,629,906

138,629,906

188,566,155

136,606,364

27,539,310

716,612,590

880,758,264

-72,125,368

15,065,784

0

-57,059,584

-15,194

1,150,879,547

117,630,709

1,268,510,256

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRTBBBDBRDBBGIS
Date   Source Headline
28th Feb 20237:00 amRNSSubsidiary acquisition right-of-use assets of land
24th Feb 202310:40 amRNSSubsidiary obtaining Fushan Technology (Vietnam)
14th Feb 20239:28 amRNSSubsidiary acquisition right-of-use assets of land
7th Feb 202310:22 amRNSSubsidiary Hon Yuan disposal Fitipower shares
6th Feb 20237:00 amRNSUn-Audited Monthly Sales Ended January 31, 2023
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
19th Jan 202312:31 pmRNSThe issue of penalty by the Investment Commission
19th Jan 202310:11 amRNSSubsidiary obtaining shares
18th Jan 202311:02 amRNSSubsidiary Foxconn (Far East) capital reduction
18th Jan 202311:00 amRNSObtaining and disposal Foxconn Singapore Shares
5th Jan 20233:47 pmRNSUn-Audited Monthly Sales Ended December 31, 2022
3rd Jan 20237:00 amRNSTo announce the obtaining of PRC investment
28th Dec 202210:38 amRNSSubsidiary obtaining Foxteq Holdings Inc. shares
28th Dec 202210:31 amRNSSubsidiary obtaining and disposal of equipment
23rd Dec 202210:10 amRNSSubsidiary obtaining and disposal of equipment
22nd Dec 202210:00 amRNSSupplement to 2022/06/14 gain on disposal
21st Dec 202211:32 amRNSProgress on FII disposing of Tsinghua Unigroup
16th Dec 20222:49 pmRNSDisposal Tsinghua Unigroup in Mainland China
15th Dec 202211:44 amRNSObtaining Hon Young Semiconductor Shares
15th Dec 202211:38 amRNSSubsidiary obtaining & disposal Shares
15th Dec 202211:33 amRNSSubsidiary obtaining and disposal of equipment
15th Dec 202211:28 amRNSFoxconn EV Tech obtaining Foxconn EV Asset Shares
12th Dec 202211:36 amRNSSubsidiary obtaining Rayprus (Foshan) shares
9th Dec 202210:30 amRNSSubsidiary INGRASYS announces obtaining Shares
8th Dec 20229:50 amRNSSubsidiary obtaining Shares
6th Dec 20229:07 amRNSMainland investment Structure Modification
5th Dec 20227:56 amRNSUn-Audited Monthly Sales Ended November 30, 2022
2nd Dec 202210:21 amRNSAdjusted 2022/01/11 announcement
2nd Dec 202210:18 amRNSSubsidiary disposal Fitipower Integrated Shares
2nd Dec 202210:14 amRNSSubsidiary obtaining Shares
28th Nov 202211:08 amRNSSubsidiary obtaining Shares
24th Nov 20229:52 amRNSSubsidiary Foxconn EV Technology obtaining Shares
23rd Nov 202210:28 amRNSExplain media reporting
11th Nov 202210:19 amRNSFII announces Resignation of supervisor
10th Nov 202212:23 pmRNSObtaining subsidiary Shares
10th Nov 202212:19 pmRNSAppointment of Chief Information Security Officer
10th Nov 202212:18 pmRNSThe consolidated financial statement 2022Q3
8th Nov 20227:00 amRNSSubsidiary participated in private placement
7th Nov 202212:47 pmRNSUn-Audited Monthly Sales Ended October 31, 2022
2nd Nov 202212:01 pmRNSSubsidiary, disposal of land use rights & building
31st Oct 202211:56 amRNSExplain media reporting
28th Oct 20221:02 pmRNSOnline Investor Conference on FY22 3rd Quarter
28th Oct 202212:49 pmRNSSubsidiary obtaining Fushan Technology (Vietnam)
20th Oct 202212:44 pmRNS111-3 Issue of Equity
4th Oct 202210:18 amRNSUn-Audited Monthly Sales Ended September 30, 2022
30th Sep 202211:13 amRNSSubsidiary its distribution of dividends
28th Sep 202212:35 pmRNSSubsidiary obtaining Shares
27th Sep 202211:02 amRNSHonxun (HangZhou) obtaining FIH (TIANJIN) Shares
26th Sep 20227:00 amRNSSubsidiary obtaining Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.